カテゴリ： , , MarketLine

New China Life Insurance Company Ltd.

◆英語タイトル：New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3486
◆発行会社（調査会社）：MarketLine
◆発行日：2019
◆ページ数：40
◆レポート言語：
◆レポート形式：PDF
◆納品方法：E
◆対象地域：
◆産業分野：Financial Services
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site LicenseUSD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide LicenseUSD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

New China Life Insurance Company Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

New China Life Insurance Company Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

New China Life Insurance Company Ltd. (NCI) provides a range of life insurance products and services to individuals and institutional customers. The company’s offerings include whole life insurance, universal life insurance, health insurance, accident insurance,annuity insurance and child insurance. It also offers group life insurance, group health insurance, critical illness insurance, investment-linked insurance and participating life insurance. The company, through its subsidiaries, offers equity investment, micro finance, real estate development and medical services. NCI also acts as an agent for domestic and international insurance companies, provides insurance related consulting services, and conducts capital management operations. It is headquartered in Beijing, China.

Scope

- Detailed information on New China Life Insurance Company Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting New China Life Insurance Company Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of New China Life Insurance Company Ltd. including a breakdown and examination of key business segments
- Intelligence on New China Life Insurance Company Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about New China Life Insurance Company Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of New China Life Insurance Company Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess New China Life Insurance Company Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on New China Life Insurance Company Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
New China Life Insurance Company Ltd.: Company Overview
New China Life Insurance Company Ltd.: Overview and Key Facts
New China Life Insurance Company Ltd.: Overview
New China Life Insurance Company Ltd.: Key Facts
New China Life Insurance Company Ltd.: Key Employees
New China Life Insurance Company Ltd.: Key Employee Biographies
New China Life Insurance Company Ltd.: Major Products and Services
New China Life Insurance Company Ltd.: Company History
New China Life Insurance Company Ltd.: Management Statement
New China Life Insurance Company Ltd.: Locations and Subsidiaries
New China Life Insurance Company Ltd.: Key Competitors
New China Life Insurance Company Ltd.: Company Analysis
New China Life Insurance Company Ltd.: Business Description
New China Life Insurance Company Ltd.: SWOT Analysis
New China Life Insurance Company Ltd.: SWOT Overview
New China Life Insurance Company Ltd.: Strengths
New China Life Insurance Company Ltd.: Weaknesses
New China Life Insurance Company Ltd.: Opportunities
New China Life Insurance Company Ltd.: Threats
New China Life Insurance Company Ltd.: Corporate Financial Deals Activity
New China Life Insurance Company Ltd.: Financial Deals Overview
New China Life Insurance Company Ltd.: Targets and Partners
New China Life Insurance Company Ltd.: Top Deals 2015 – 2019YTD*
New China Life Insurance Company Ltd.: Mergers and Acquisitions
New China Life Insurance Company Ltd.: Corporate Venturing
New China Life Insurance Company Ltd.: Private Equity and Ownership
New China Life Insurance Company Ltd.: Recent Developments
New China Life Insurance Company Ltd.: News and Events Summary
New China Life Insurance Company Ltd.: Business Expansion
New China Life Insurance Company Ltd.: Corporate Governance
New China Life Insurance Company Ltd.: Financial Deals
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: New China Life Insurance Company Ltd.: Key Facts
Table 2: New China Life Insurance Company Ltd.: Key Employees
Table 3: New China Life Insurance Company Ltd.: Company History
Table 4: New China Life Insurance Company Ltd.: Locations and Subsidiaries
Table 5: New China Life Insurance Company Ltd.: Key Competitors
Table 6: New China Life Insurance Company Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: New China Life Insurance Company Ltd.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: New China Life Insurance Company Ltd.: M&A Average Deal Size - Value (US$m)
Table 9: New China Life Insurance Company Ltd.: Targets and Partners
Table 10: New China Life Insurance Company Ltd.: Top Deals 2015 - 2019YTD*
Table 11: New China Life Insurance Company Ltd.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 12: New China Life Insurance Company Ltd.: M&A Activity by Geography (2015 - YTD*2019)
Table 13: New China Life Insurance Company Ltd.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 14: New China Life Insurance Company Ltd.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 15: New China Life Insurance Company Ltd.: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Table 16: New China Life Insurance Company Ltd.: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)
Table 17: New China Life Insurance Company Ltd.: News and Events Summary
Table 18: New China Life Insurance Company Ltd.: Business Expansion
Table 19: New China Life Insurance Company Ltd.: Corporate Governance
Table 20: New China Life Insurance Company Ltd.: Financial Deals

★海外企業調査レポート[New China Life Insurance Company Ltd.]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • U.S. HealthWorks Medical Group：製薬・医療：M&Aディール及び事業提携情報
    Summary U.S. HealthWorks Medical Group (U.S. HealthWorks), a subsidiary of Dignity Health, is a healthcare service provider that offers medicine and urgent care services. The center’s services include occupational medicine, urgent care, specialty care and therapy services. Its occupational medicine …
  • Paymark：企業の戦略的SWOT分析
    Paymark - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Saladax Biomedical Inc：医療機器：M&Aディール及び事業提携情報
    Summary Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, M …
  • Eiger BioPharmaceuticals Inc (EIGR)：製薬・医療：M&Aディール及び事業提携情報
    Summary Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are …
  • SeaWorld Entertainment Inc：戦略・SWOT・企業財務分析
    SeaWorld Entertainment Inc - Strategy, SWOT and Corporate Finance Report Summary SeaWorld Entertainment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Woolworths Limited：企業の戦略・SWOT・財務情報
    Woolworths Limited - Strategy, SWOT and Corporate Finance Report Summary Woolworths Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MCC EuroChem：企業の戦略的SWOT分析
    MCC EuroChem - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Anteo Diagnostics Ltd (ADO)：企業の財務・戦略的SWOT分析
    Anteo Diagnostics Ltd (ADO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Uppsala University：企業のM&A・事業提携・投資動向
    Uppsala University - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Uppsala University Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Technogenetics srl：医療機器：M&Aディール及び事業提携情報
    Summary Technogenetics srl (Technogenetics), a subsidiary of Shanghai Kehua Bio-engineering Co Ltd, is an immunodiagnostics and molecular genetics company that offers reagents and instruments in the field of biotechnology and pharmacology. The company provides immunodiagnostics products in the areas …
  • Targa Resources Partners LP (NGLS PR A)-石油・ガス分野：企業M&A・提携分析
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. The company provides midstream natural gas and natural gas liquids (NGL) services. Targa Resources carries out the gathering, compressing, treating, processing and selling of natural gas, and storing, fraction …
  • Envision Solar International Inc (EVSI)：電力：M&Aディール及び事業提携情報
    Summary Envision Solar International Inc (Envision Solar) is a provider of energy security systems. The company's products include renewably energized electric vehicle charging systems, media and branding systems, energy security systems, patented solar tracking systems, energy storage systems, elec …
  • ICL Group Ltd (ICL)：企業の財務・戦略的SWOT分析
    ICL Group Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nobelpharma Co Ltd-製薬・医療分野：企業M&A・提携分析
    Summary NobelPharma Co Ltd (NobelPharma) is a pharmaceutical company which develops medicines for rare diseases and unmet medical needs. The Company’s pipeline products include NPC-07, NPC-09, NPC-12, NPC-14, NPC-15, NPC-16, NPC-17 and NPC-18. It offers its products in the therapeutic areas of oncol …
  • Rafa Laboratories Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Rafa Laboratories Ltd (Rafa) is a pharmaceutical company that manufactures and distributes medicines and consumer health products. The company offers prescription, over-the-counter medicines, proprietary formulations, generic formulations and consumer health products. It offers scale-up and …
  • Beth Israel Deaconess Medical Center Inc-製薬・医療分野：企業M&A・提携分析
    Summary Beth Israel Deaconess Medical Center Inc (BIDMC), a subsidiary of CareGroup Inc is a healthcare center that offers clinical care, biomedical research and education, health and wellness services. The center offers patient and family care services such as admitting, case management, ethics sup …
  • Brazos Electric Cooperative, Inc.：企業の戦略的SWOT分析
    Brazos Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Centrotec Sustainable AG (CEV)：企業の財務・戦略的SWOT分析
    Summary Centrotec Sustainable AG (Centrotec) is an energy company that provides energy saving systems. The company provides products such as medical technology plastics, climate systems, gas flue systems and engineering plastics, among others. It also offers ventilation with heat recovery, heating s …
  • Emerald Resources NL (EMR)：企業の財務・戦略的SWOT分析
    Summary Emerald Resources NL (Emerald) is an oil and gas company that carries out mineral exploration and development. The company carries out acquisition, exploration, development and produces oil and natural gas, and gold deposits. Its projects include Okavu Gold project, and Magoffin County proje …
  • ContraFect Corp (CFRX)：企業の財務・戦略的SWOT分析
    Summary ContraFect Corp (ContraFect) is a clinical stage biotechnology company that discovers and develops therapeutic protein and antibody products. The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious diseases. …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆